Valuation: BillionToOne, Inc.

Market Cap 4.85B 4.33B 4.02B 3.66B 6.88B 459B 7.01B 48.31B 18.9B 240B 18.19B 17.81B 767B P/E 2026 *
132x
P/E 2027 * 102x
Enterprise Value 5.32B 4.75B 4.41B 4.02B 7.55B 504B 7.69B 53.03B 20.75B 263B 19.97B 19.55B 841B EV / Sales 2026 *
11.7x
EV / Sales 2027 * 9.5x
Free-Float
74.3%
Yield 2026 *
-
Yield 2027 * -
1 day+4.96%
1 week+7.67%
Current month-3.49%
1 month-1.48%
3 months-20.90%
6 months+27.44%
Current year+25.53%
1 week 90.48
Extreme 90.48
102.93
1 month 90.48
Extreme 90.48
127.72
Current year 61.96
Extreme 61.96
150.44
1 year 61.96
Extreme 61.96
150.44
3 years 61.96
Extreme 61.96
150.44
5 years 61.96
Extreme 61.96
150.44
10 years 61.96
Extreme 61.96
150.44
Manager TitleAgeSince
President 36 31/12/2015
Chief Executive Officer 37 31/12/2015
Director of Finance/CFO 62 31/12/2023
Director TitleAgeSince
Chairman 37 31/12/2015
Director/Board Member 36 31/12/2015
Director/Board Member 62 28/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
08/10/26 Exercice

Compliance Officer

16,000 0.0375%
05/10/26 Exercice

Founder

60,000 0.1407%
05/10/26 Sell

Executive/Senior Manager

-2,834 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
+4.96%+7.67% - - 4.85B
+0.21%-4.63%+55.34%+71.32% 68.98B
-1.45%+2.58%+5.06%+58.98% 53.15B
-0.98%+4.61%+9.19%+40.48% 50.83B
+3.45%+4.70%+33.44%+35.96% 44.61B
-2.20%+0.61%+281.88%+532.76% 40.57B
+6.43%+6.84%+18.32%+109.23% 42.53B
+1.28%+1.39%+11.69%+45.10% 30.95B
-0.90%-10.49%+31.48%-1.63% 25.44B
+1.74%-2.02%-13.55%-12.92% 22.66B
Average +1.17%+2.17%+48.09%+97.70% 38.46B
Weighted average by Cap. +0.75%+2.40%+50.34%+102.80%

Financials

2026 *2027 *
Net sales 455M 406M 377M 343M 646M 43.07B 657M 4.53B 1.77B 22.47B 1.71B 1.67B 71.92B 574M 512M 476M 433M 815M 54.34B 829M 5.72B 2.24B 28.35B 2.15B 2.11B 90.73B
Net income 42.86M 38.25M 35.55M 32.34M 60.84M 4.06B 61.94M 427M 167M 2.12B 161M 157M 6.78B 59.89M 53.46M 49.69M 45.2M 85.03M 5.67B 86.57M 597M 234M 2.96B 225M 220M 9.47B
Net Debt 474M 423M 393M 357M 672M 44.86B 685M 4.72B 1.85B 23.41B 1.78B 1.74B 74.9B 604M 539M 501M 455M 857M 57.17B 872M 6.01B 2.35B 29.83B 2.27B 2.22B 95.45B
Projected Income Statement - Annual - BillionToOne, Inc.
Logo BillionToOne, Inc.
BillionToOne, Inc. is a precision diagnostics company that quantifies biology to create molecular diagnostics. The Company's proprietary molecular counting platform is designed to detect and measure deoxyribonucleic acid (DNA) molecules at a single-count level to help improve disease detection. It applies the proprietary technology to non-invasive prenatal screening (Prenatal) and liquid biopsy (Oncology). Its Quantitative Counting Templates (QCTs), power its ability to detect and measure tiny and sparse disease-related DNA fragments, or molecules, at the single base-pair level. These include pregnancy-related DNA that code for recessively inherited conditions such as sickle cell disease and cystic fibrosis and ctDNA in the case of cancer. Its prenatal products include UNITY Complete, UNITY Fetal Risk Screen, UNITY Aneuploidy Screen, UNITY Fetal RhD NIPT, UNITY Fetal Antigen NIPT, and UNITY Fetal Antigen CTA NIPT. Its oncology products include Northstar and Northstar Select.
Employees
713
Date Price Change Volume
15/10/26 US$102.73 +4.96% 427,230
14/10/26 US$97.88 +3.64% 424,933
13/10/26 US$94.44 +1.47% 664,221
12/10/26 US$93.07 -5.12% 491,517
09/10/26 US$98.09 +2.81% 325,044
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BillionToOne, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
102.73USD
Average target price
129.00USD
Spread / Average Target
+25.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BillionToOne, Inc.
  1. Stock Market
  2. Stocks
  3. BLLN Stock